Redeye returns with an update following Paxman’s takeover offer to Dignitana and the directed share issue. We update our forecasts and valuation assuming that the offer is accepted. Furthermore, we are positive about the offer, and the changes we have made to our estimates render an increased fair value range.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/